Commercialisation Strategy and Delivery Model for Wales

The scope of this PIN will include:

1. Sharing knowledge and experiences regarding current commercialisation practices and their potential application to health care in Wales/UK.
2. Sharing knowledge and experiences regarding routes to engaging and contracting between health organisations and commercial partners or other parties (industry, universities, or other parties)
3. Sharing knowledge and experiences of working within regulatory frameworks, including mechanisms for financial management that supports innovation activity to become self-sustaining.
4. Sharing knowledge regarding how realising commercial value may be achieved, such as mechanisms for reduced cost or ‘Value-Based health’ improved citizen outcomes calculation, and revenue share.
5. Advice to support the formulation of strategic recommendations for management of activities relating to commercialisation.

Industry partners with experience in commercialisation, particularly within the Health sector, are invited to express their interest. Partners should have a proven track record of developing and implementing commercialisation strategies and be able to support the commercialisation within the context of the health sector in Wales/UK.

Parties expressing an interest in this PIN (via an email to the contact outlined in this notice) will be invited to complete an online survey. Those submitting a survey may then be invited to join a follow up online engagement session from 10:00 to 11:00 on 18th September 2024.

The online engagement sessions will be led by Academic Health Solutions with facilitation by:

Mr Neil Mesher is the former Chief Executive of Phillips Healthcare in the UK, Ireland and Northern Europe. Neil has overseen partnerships between industry and health services such as cardiac device development, digital pathology and lung screening. He also works with start-up companies working in health services. He is a former chair of the Association of British Health Tech Industries, and is a current member of the UK Life Sciences Council and the Life Sciences Hub Wales.

Mr Malcolm Lowe-Lauri has worked in health and life sciences as a leader and adviser for over 40 years. He has led projects on innovation, commercialisation, investment and ecosystem development in Wales since 2021. He has done similar work for trusts in England, universities and major research charities. Alongside this work he advises universities and research organisations on strategy and operating model change. He is a Non-Executive Director of the Life Sciences Hub Wales and a Trustee for the Warrior Programme, a charity working with service men and women, veterans and their families. Malcolm will co-ordinate the project if AHS is successful.

Any costs advised within this PIN are an estimate at this stage and subject to ongoing programme development.

It is unlikely that any subsequent procurement will occur as a direct follow on from this early market engagement.

Participation in developing this Commercial Strategy and Delivery Model development through sharing experiences, insights and preferred ways of working may influence the processes and mechanisms for future procurement.

Any further updates regarding future activity will be made through the appropriate advertising channels. Additional information: Following the review of submissions, selected partners may be invited to participate in further engagement on 18th September 2024. All responses will be used to inform development of the commercialisation strategy.